Abstracts
NSCLC, metastatic
1303PD - Nivolumab in previously treated patients with metastatic squamous NSCLC: Results of a European single-arm, phase 2 trial (CheckMate 171) including patients aged ≥70 years and with poor performance status

https://doi.org/10.1093/annonc/mdx380.006Get rights and content
Under an Elsevier user license
open archive

Cited by (0)